National HealthcareNHC.AValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, National Healthcare (NHC.A) trades at a P/E of 27.10x, P/B of 3.39x, P/S of 2.44x, and a dividend yield of 0.82%.
Longitudinal percentile comparison: P/E sits at the 79th percentile over the trailing 10Y window (vs. 98th percentile over 3Y); P/B sits at the 100th percentile over the trailing 10Y window (vs. 100th percentile over 3Y); P/S sits at the 100th percentile over the trailing 10Y window (vs. 100th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 58th percentile within its industry and the 65th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.21%, ranking at the 0th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 20.9 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 0.82% comes from cash dividends, with an implied ~0.39% from buybacks — a fairly balanced mix of both channels. National Healthcare operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether National Healthcare (NHC.A) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 27.10 | ||||||
| P/B (MRQ) | 3.39 | ||||||
| P/S (TTM) | 2.44 | ||||||
| Dividend Yield | 0.82% | ||||||
| Buyback + Div Yield | 1.21% |